癌症中的KLF9:潜在的预后标志物和治疗标
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
在PubMed上查看摘要
概括
此摘要是机器生成的。克鲁佩尔类因子9 (KLF9) 在癌症中具有双重作用,作为瘤抑制剂或瘤基因. 它的表达水平可以预测患者的结果,KLF9是个性化癌症药物的潜在治疗标.
科学领域
- 分子生物学
- 癌症学
- 遗传学
背景情况
- 克鲁佩尔类因子9 (KLF9) 是一种涉及癌症的转录因子.
- 它在瘤形成中的作用取决于环境,作为瘤抑制剂或瘤基因.
- 在不同类型的癌症中,KLF9表现不同,影响患者的预后.
研究的目的
- 审查KLF9在癌症发展和进展中的多方面的作用.
- 突出KLF9作为预后生物标志物和治疗目标.
- 为未来的研究和个性化癌症医学提供洞察力.
主要方法
- 关于KLF9在癌症中的最新研究的文献综述.
- 分析KLF9在瘤发生中的双重功能.
- 检查KLF9作为生物标志物和治疗点的临床意义.
主要成果
- KLF9在癌症中表现出特定的功能,作为瘤抑制剂或瘤基因.
- 较低的KLF9表达通常与患者的不良结果相关.
- KLF9调节为新型癌症疗法提供了一个有前途的途径.
结论
- KLF9是癌症的关键因素,具有显著的预后和治疗影响.
- 了解KLF9的双重作用对于开发有效的个性化癌症治疗至关重要.
- KLF9是未来癌症研究和精准医学战略的关键目标.
相关概念视频
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...